2017
DOI: 10.1111/his.13389
|View full text |Cite
|
Sign up to set email alerts
|

From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma

Abstract: We present for the first time a direct comparison between surgical specimens and needle biopsies to confirm the usefulness and reproducibility of the most widely used antibodies for the diagnosis of small liver nodules. Our results support the use of IHC evaluation in biopsies for the diagnosis of small liver lesions, although the IHC panel could also give negative results in the presence of obvious HCC, and the possibility of false positives should always be considered.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 22 publications
(55 reference statements)
0
4
0
Order By: Relevance
“…In certain case, the chaperone can be both structurally and functionally normal but just get participated in pathways that lead to disease. For instance, the post-translational modification of the chaperone could alter its subcellular localization and subsequent function 1720,28–30. Moreover, high expression of chaperone can lead to superabundant protein synthesis, which is a common feature of a wide variety of tumors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In certain case, the chaperone can be both structurally and functionally normal but just get participated in pathways that lead to disease. For instance, the post-translational modification of the chaperone could alter its subcellular localization and subsequent function 1720,28–30. Moreover, high expression of chaperone can lead to superabundant protein synthesis, which is a common feature of a wide variety of tumors.…”
Section: Discussionmentioning
confidence: 99%
“…HSP10 and HSP70 proteins were located in the cytoplasm. A semi-quantitative evaluation of HSP10 and HSP70 expression was performed using a method described in the literature2628: staining intensity for HSP10 and HSP70 were divided into four grades (intensity scores): as 0 (negative, no staining), 1 (weak, light brown), 2 (moderate, brown), and 3 (strong, dark brown). The positive percentage was divided into five grades (percentage scores): 0 (0%), 1 (1–25%), 2 (26–50%), 3 (51–75%), and 4 (76–100%).…”
Section: Methodsmentioning
confidence: 99%
“…Other pathologic variables have also been analyzed and correlated to tumor behaviors, such as encapsulation, intratumor steatosis, and tumor-infiltrating cells [ 5 , 6 , 7 ]. The tumor heterogeneity in HCC indicates that pathological subtypes could be helpful in the subclassification of HCC in addition to tumor staging, where glutamine synthase (GS), glypican-3 (GPC-3), heat shock protein 70 (Hsp70), and enhancer of zeste homologue 2 (EZH2) are the common markers for HCC diagnosis [ 8 ]. Biliary/stem cell markers and Wnt/β-catenin signaling have been used for the three-group classification of HCC [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…In cases where non-invasive imaging results are ambiguous, HCC is diagnosed by histologic features of biopsy tissue. Accuracy of diagnosis is improved by immunohistochemical (IHC) analysis for established biomarkers, such as glypican 3 (GPC3), heat shock protein 70 (HSP70), and glutamine synthetase (GS) [ 18 20 ]. However, the molecular complexity of HCC presents challenges finding reliable biomarkers for all patients [ 21 ].…”
Section: Introductionmentioning
confidence: 99%